These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 34491822)
1. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study. Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S Br J Radiol; 2021 Nov; 94(1127):20210788. PubMed ID: 34491822 [TBL] [Abstract][Full Text] [Related]
2. Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy. Weiss A; King C; Vincuilla J; Parker T; Portnow L; Nakhlis F; Dominici L; Mittendorf EA; King TA Breast Cancer Res Treat; 2022 Sep; 195(2):181-189. PubMed ID: 35900704 [TBL] [Abstract][Full Text] [Related]
3. Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy. Cabıoğlu N; Karanlık H; Yılmaz R; Emiroğlu S; Tükenmez M; Bademler S; Şimşek DH; Kantarcı TR; Yirgin İK; Bayram A; Dursun M World J Surg Oncol; 2024 Jul; 22(1):178. PubMed ID: 38971793 [TBL] [Abstract][Full Text] [Related]
4. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study. Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348 [TBL] [Abstract][Full Text] [Related]
5. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050 [TBL] [Abstract][Full Text] [Related]
6. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment. Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
8. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793 [TBL] [Abstract][Full Text] [Related]
9. The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients. Leinert E; Lukac S; Schwentner L; Coenen A; Fink V; Veselinovic K; Dayan D; Janni W; Friedl TWP Surg Oncol; 2024 Feb; 52():102016. PubMed ID: 38056112 [TBL] [Abstract][Full Text] [Related]
10. The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? Farrell TP; Adams NC; Stenson M; Carroll PA; Griffin M; Connolly EM; O'Keeffe SA Eur Radiol; 2015 Sep; 25(9):2682-7. PubMed ID: 25740803 [TBL] [Abstract][Full Text] [Related]
11. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528 [TBL] [Abstract][Full Text] [Related]
12. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study. Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843 [TBL] [Abstract][Full Text] [Related]
14. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy? Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791 [TBL] [Abstract][Full Text] [Related]
15. How much does axillary ultrasound contribute in women undergoing breast-conserving surgery with no palpable axillary nodes? Preda T; McGrath R; Bingham J; Fawcett A; O'Dea C; Bochner M; Gill PG; Kollias J ANZ J Surg; 2020 Jun; 90(6):1146-1150. PubMed ID: 31957192 [TBL] [Abstract][Full Text] [Related]
16. Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection. Harris CK; Tran HT; Lee K; Mylander C; Pack D; Rosman M; Tafra L; Umbricht CB; Andrade R; Liang W; Jackson RS Ann Surg Oncol; 2017 Oct; 24(10):3004-3010. PubMed ID: 28766210 [TBL] [Abstract][Full Text] [Related]
17. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature. Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672 [TBL] [Abstract][Full Text] [Related]
18. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients. Pinto CS; Peleteiro B; Pinto CA; Osório F; Costa S; Magalhães A; Mora H; Amaral J; Gonçalves D; Fougo JL Breast Cancer; 2022 Jul; 29(4):709-719. PubMed ID: 35304711 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment. Siso C; Esgueva A; Rivero J; Morales C; Miranda I; Peg V; Gil-Moreno A; Espinosa-Bravo M; Rubio IT Eur J Surg Oncol; 2023 Oct; 49(10):106938. PubMed ID: 37244843 [TBL] [Abstract][Full Text] [Related]
20. The role of preoperative axillary ultrasound and fine-needle aspiration cytology in identifying patients with extensive axillary lymph node involvement. Maráz R; Zombori T; Ambrózay É; Cserni G Eur J Surg Oncol; 2017 Nov; 43(11):2021-2028. PubMed ID: 28919032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]